Skip to main content
. 2017 Sep 15;8(52):89903–89912. doi: 10.18632/oncotarget.20911

Table 2. Association between PD-L1-positivity and clinicopathological features of vSCC patients.

CC-PD-L1(pos.) CC-PD-L1(neg.) p IC -PD-L1(pos.) IC -PD-L1(neg.) p
pT 1/2/3 24/3/0 51/5/1 p=0.748 48/3/0 27/5/1 p=0.158
Meta +/- 14/13 25/32 p=0.640 25/26 14/19 p=0.656
Grade 1/2+3 9/18 18/39 p=1.000 17/34 10/23 p=0.815
Age 68 (36-82) 68 (40-85) p=0.523 66 (36-85) 71 (44-85) p=0.072
Depth of invasion 7.0 (2.0-18.0) 7.6 (2.0-16.0) p=0.361 7.0 (2.0-18.0) 7.5 (2.0-13.0) p=0.502